- Meihua International Medical Technologies Co., Ltd. entered into a securities purchase agreement on **October 8, 2025**, for a private placement.  **[1835615_0001213900-25-098827_ea0260630-6k_meihua.htm:0]** 
- The company agreed to sell up to **40,000,000 ordinary shares** at a purchase price of **$0.38 per share**, for **gross proceeds of $15.2 million**.  **[1835615_0001213900-25-098827_ea0260630-6k_meihua.htm:0]** 
- The net proceeds from the offering are intended for **working capital and general corporate purposes**.  **[1835615_0001213900-25-098827_ea0260630-6k_meihua.htm:0]** **[1835615_0001213900-25-098827_ea026063001ex99-1_meihua.htm:12]** 
- The shares were issued to "non-U.S. Persons" in reliance on the exemption from registration provided by **Regulation S** under the Securities Act of 1933.  **[1835615_0001213900-25-098827_ea0260630-6k_meihua.htm:0]** **[1835615_0001213900-25-098827_ea026063001ex99-1_meihua.htm:0]** **[1835615_0001213900-25-098827_ea026063001ex99-1_meihua.htm:7]** 
- As of the date of the agreement, the number of total Class A Ordinary Shares issued and outstanding was **31,904,468**.  **[1835615_0001213900-25-098827_ea026063001ex99-1_meihua.htm:2]**

Meihua International Medical Technologies Co., Ltd. Enters into Private Placement

- Meihua International Medical Technologies Co., Ltd. reported a **16.2% decrease** in total revenues to **$37.98 million** for the six months ended June 30, 2025, down from $45.34 million in the prior year, primarily due to a decline in customer demand.  **[1835615_0001213900-25-089047_ea025718201ex99-2_meihua.htm:0]** **[1835615_0001213900-25-089047_ea025718201ex99-2_meihua.htm:1]** 
- Net income for the six months ended June 30, 2025, **decreased by 33.0%** to **$3.15 million**, compared to $4.71 million in the same period of 2024, mainly due to a decrease in gross profit and an increase in expected credit loss.  **[1835615_0001213900-25-089047_ea025718201ex99-2_meihua.htm:0]** **[1835615_0001213900-25-089047_ea025718201ex99-2_meihua.htm:1]** 
- Gross profit for the six months ended June 30, 2025, was **$12.61 million**, representing a **16.9% decrease** from $15.19 million in the prior year, with the gross profit margin declining from 33.5% to **33.2%**.  **[1835615_0001213900-25-089047_ea025718201ex99-2_meihua.htm:2]** 
- The company experienced **net cash used in operating activities of $9.9 million** for the six months ended June 30, 2025, a shift from net cash provided of $1.0 million in the corresponding period of 2024.  **[1835615_0001213900-25-089047_ea025718201ex99-2_meihua.htm:4]** **[1835615_0001213900-25-089047_ea025718201ex99-2_meihua.htm:5]**

Meihua International Medical Technologies (MHUA)